CAS: 949164-09-4
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | ALX-1393 REF: 54-BUP09000CAS: 949164-09-4 | 99.72% | 7.226,00 €~15.674,00 € | Di 15 Apr 25 |
 | ALX-1393 REF: TM-T14198CAS: 949164-09-4 | 99.73% | 1.311,00 €~9.377,00 € | Mo 02 Jun 25 |
 | ALX-1393 REF: 3D-ZMB16409CAS: 949164-09-4 | Min. 95% | 920,00 €~4.697,00 € | Mo 23 Jun 25 |
Ref: 54-BUP09000
| 25mg | 7.226,00 € | ||
| 50mg | 9.759,00 € | ||
| 100mg | 12.690,00 € | ||
| 200mg | 15.674,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 15. April 2025
ALX-1393
CAS:949164-09-4
ALX-1393 is a selective GlyT2 inhibitor that effectively reduces neuronal action potential activity in a …
Formel:
C23H22FNO4
Reinheit:
99.73%
Farbe und Form:
Solid
Molekulargewicht:
395.42
Ref: TM-T14198
| 1mg | 1.311,00 € | ||
| 5mg | 2.660,00 € | ||
| 10mg | 3.591,00 € | ||
| 25mg | 5.339,00 € | ||
| 50mg | 7.210,00 € | ||
| 100mg | 9.377,00 € | ||
| 1mL*10mM (DMSO) | 2.737,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 2. Juni 2025
ALX-1393
CAS:949164-09-4
Please enquire for more information about ALX-1393 including the price, delivery time and more detailed …
Formel:
C23H22FNO4
Reinheit:
Min. 95%
Molekulargewicht:
395.4 g/mol
Ref: 3D-ZMB16409
| 1g | 4.697,00 € | ||
| 50mg | 920,00 € | ||
| 100mg | 1.283,00 € | ||
| 250mg | 2.315,00 € | ||
| 500mg | 3.429,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 23. Juni 2025
